IGFBP5 and glioblastoma: Both pure cultures of GBM subpopulations (2 independent preparations of GSCs and more differentiated GBM cells each) responded to mFUS treatment with increased mRNA expression of dormancy- and stemness-associated markers, with the most consistent findings for SKI, IGFBP5, OCT4, and Nestin.